| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Adaptive Biotechnologies Corporation (ADPT) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. ADPT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.18M | $29.82M | - | |
| Other | 1.51M | $20.68M | - | |
| Other | 427.8K | $5.85M | - | |
| COO | 396.8K | $5.43M | -259,638 | |
| Other | 272.8K | $3.73M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | Robins Harlan S85 | Chief Scientific Officer | Sell | 37,212 | $18.07 | $672,515.32 | -1.5% | -5.8% | - | |
| Dec 1, 2025 | Robins Chad M63 | CEO And Chairman | Sell | 160,734 | $19.10 | $3,070,746.60 | -2.8% | -14.5% | - | |
| Nov 28, 2025 | Piskel Kyle | Chief Financial Officer | Sale+OE | 162,820 | $19.50 | $3,174,990.00 | -42.9% | -16.3% | - | |
| Nov 21, 2025 | Benzeno Sharon79 | Chief Commercial Ofc Imm Med | Sale+OE | 606,402 | $16.73 | $10,144,025.57 | -50.5% | -13.8% | - | |
| Nov 17, 2025 | Piskel Kyle | Chief Financial Officer | Sell | 238 | $14.05 | $3,343.90 | - | +15.2% | - | |
| Nov 12, 2025 | Robins Chad M63 | CEO And Chairman | Sell | 89,265 | $14.73 | $1,315,179.62 | -1.0% | +7.9% | - | |
| Nov 10, 2025 | Robins Harlan S85 | Chief Scientific Officer | Sell | 10,000 | $14.82 | $148,200.00 | -0.8% | +7.8% | - | |
| May 16, 2025 | Piskel Kyle | Chief Financial Officer | Sell | 1,929 | $8.89 | $17,148.81 | -0.7% | +42.8% | - | |
| May 1, 2025 | Robins Harlan S85 | Chief Scientific Officer | Sale+OE | 68,412 | $7.35 | $502,828.20 | -5.1% | +41.8% | +93.9% | |
| Mar 24, 2025 | Robins Harlan S85 | Chief Scientific Officer | Sale+OE | 1,698 | $9.00 | $15,282.00 | -0.1% | +21.9% | +60.5% |